NCT05267938

Brief Summary

A randomized, crossover, double-blind, two-sessions clinical trial with 30 male volunteers was performed to access pain of local anesthesia after using a topical anesthetic associated or not with prior application of microneedles to the palatal mucosa region

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Aug 2019

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2020

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 23, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 7, 2022

Completed
Last Updated

March 21, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

February 23, 2022

Last Update Submit

March 4, 2022

Conditions

Keywords

MicroneedlesOral CavityTransbuccal administration

Outcome Measures

Primary Outcomes (1)

  • Pain sensitivity assessment by Visual Analogue Scale after the after puncture and injection of local anesthetic

    Microneedles or the negative control were used to prepare the palatal mucosa to receive the topical anesthetic, followed by the insertion of the needle and injection of the local anesthetic, evaluating whether the microneedles improve the effectiveness of the topical agent with a Visual Analogic Scale. The blind investigator, evaluated the values with a rule, the left far end mean 0, for no pain at all and the right far end mean 100 for maximum pain. Therefore, a higher score means a worse outcome,

    2 minutes or 5 minutes

Study Arms (2)

Microneedles

EXPERIMENTAL

Microneedles is with 750μm of height in order to prepare the palatal mucosa to receive the topical anesthetic

Drug: Topical AnestheticDrug: Local anesthetic

patch flat

SHAM COMPARATOR

The same device as the microneedles but without microneedles

Drug: Topical AnestheticDrug: Local anesthetic

Interventions

The topical anesthetic used in this experimental is EMLA® after the pre-treatment of the palatal mucosa

Also known as: treatment
Microneedlespatch flat

After the pre-treatment with microneedles and the use of topical anesthetic, the needle and injection of local anesthetic was inserted and pain was evaluated

Also known as: Lidocaine with epinephrine
Microneedlespatch flat

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- Healthy male

You may not qualify if:

  • Volunteers were free from cardiac, hepatic, renal, pulmonary, neurological, gastrointestinal and haematological diseases, psychiatric disorders, smokers or alcoholic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michelle Franz Montan Braga Leite

Piracicaba, São Paulo, 13414903, Brazil

Location

MeSH Terms

Conditions

Mouth Diseases

Interventions

Anesthetics, LocalTherapeuticsLidocaineEpinephrine

Condition Hierarchy (Ancestors)

Stomatognathic Diseases

Intervention Hierarchy (Ancestors)

AnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic UsesAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Every volunteers has received bilateral pre-treatment with microneedles or the negative control in the palatal mucosa, in both sessions, which each session was 2 minutes of topical anesthetic or 5 minutes.
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 23, 2022

First Posted

March 7, 2022

Study Start

August 1, 2019

Primary Completion

October 30, 2019

Study Completion

January 30, 2020

Last Updated

March 21, 2022

Record last verified: 2022-03

Locations